ReShape Lifesciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,292 | $1,965 | $1,944 | $1,982 |
Gross Profit | 1,439 | 1,134 | 1,165 | 1,842 |
EBITDA | -1,756 | -2,048 | -2,204 | |
EBIT | -1,761 | -2,054 | -2,210 | |
Net Income | -1,581 | -1,595 | -2,193 | -1,698 |
Net Change In Cash | 2,292 | 1,965 | 1,944 | 1,982 |
Free Cash Flow | -311 | -1,357 | -2,072 | -2,457 |
Cash | 743 | 1,053 | 2,479 | 4,459 |
Basic Shares | 508 | 434 | 404 | 23,457 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $8,678 | $11,240 | $13,600 | $11,299 |
Gross Profit | 5,548 | 6,802 | 8,348 | 6,262 |
EBITDA | -14,485 | -24,925 | -25,778 | -10,790 |
EBIT | -14,639 | -27,078 | -27,749 | -12,457 |
Net Income | -11,387 | -46,214 | -61,933 | -21,630 |
Net Change In Cash | 8,678 | 11,240 | 13,600 | 11,299 |
Cost of Revenue | 135 | |||
Free Cash Flow | -17,003 | -22,033 | -15,727 | -8,940 |
Cash | 4,459 | 3,855 | 22,765 | 2,957 |
Basic Shares | 102 | 7 | 3 | 26 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$3.10 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.09 |
2023-12-31 | -$0.11 |
